Experienced, highly motivated and versatile Research Chemist with over 20 years of working in the pharmaceuticals industry, primarily in process research and development (PR&D) in organic chemistry. I am interested in finding and implementing solutions for complex and challenging technical problems in synthetic and process chemistry.While working in pharmaceuticals, I had a strong focus on the application of asymmetric chemocatalysis and biocatalysis to APIs and synthons, including designing and testing novel ligands for catalysis, and also in evaluation, discovery and development of viable synthetic routes to complex APIs, characterisation issues of complex APIs and experience of technical leadership of multi-disciplinary teams of scientists in projects in these areas.Now, I have moved to biotechnology, where I expanded my interest in complex molecules and challenging chemistry problems and led the effort to design and produce the building blocks in Nuclera's enzyme-based DNA synthesis programme. Subsequently, I led the development of chemistry-based applications, for Nuclera's eProtein bioprinter, especially those important in the drug-discovery field, such as the screening of DNA-encoded libraries of small molecules. Implementation of this technology requires precise orchestration of biochemistry and microfluidics. I am working on a project with a partner company to apply machine learning to analysis of the complex datasets generated from screening of these libraries in identifying leads for drug discovery. I am also working on Nuclera's Generation 2 eProtein Discovery product, which aims to use the microfluidic device for screening conditions for production of mammalian proteins by culture of mammalian cells on the microfluidic device.